KENDEE KOSTER: Open Payments
NPI 1285718072 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 12 payments from 11 companies in 2025. Trend: 2023 $186 · 2024 $252 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $51 |
| Genentech USA, Inc. | 1 | $29 |
| Medtronic, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Ocrevus Zunovo, SYMPLICITY G3, Kerendia, CREON, LINZESS, OMVOH, ENTYVIO, AUSTEDO XR.
Industry payments across NE — which companies pay providers there.
